Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhe Sheng

Showing results (501-510 of 633) with videos related to

Pageof 64
Sort By:
Cancer Letters|October 31, 2024
Mobocertinib antagonizes multidrug resistance in ABCB1- and ABCG2-overexpressing cancer cells: In vitro and in vivo studiesXing-Duo Dong, Meng Zhang, Qiu-Xu Teng, et al.
Frontiers in Oncology|July 1, 2022
ERH Interacts With EIF2α and Regulates the EIF2α/ATF4/CHOP Pathway in Bladder Cancer CellsKun Pang, Yang Dong, Lin Hao, et al.
Frontiers in Oncology|November 9, 2020
Sapitinib Reverses Anticancer Drug Resistance in Colon Cancer Cells Overexpressing the ABCB1 TransporterHai-Ling Gao, Pranav Gupta, Qingbin Cui, et al.
Frontiers in Cell and Developmental Biology|January 11, 2021
Establishment and Characterization of a Topotecan Resistant Non-small Cell Lung Cancer NCI-H460/TPT10 Cell LineZi-Ning Lei, Qiu-Xu Teng, Wei Zhang, et al.
Molecular Cancer|September 4, 2020
Characterization of a novel HDAC/RXR/HtrA1 signaling axis as a novel target to overcome cisplatin resistance in human non-small cell lung cancerWenjing Wang, Mengyue Zhao, Lijuan Cui, et al.
Molecular Pharmacology|April 9, 2005
Analysis of the in vivo functions of Mrp3Martin G Belinsky, Paul A Dawson, Irina Shchaveleva, et al.
Cancers|September 28, 2021
VKNG-1 Antagonizes ABCG2-Mediated Multidrug Resistance via p-AKT and Bcl-2 Pathway in Colon Cancer: In Vitro and In Vivo StudySilpa Narayanan, Ying-Fang Fan, Nehaben A Gujarati, et al.
ACS Nano|January 24, 2024
Bioactive Ceria Nanoenzymes Target Mitochondria in Reperfusion Injury to Treat Ischemic StrokeJun Liao, Yi Li, Li Fan, et al.
Biochemical Pharmacology|August 11, 2010
Marine sponge-derived sipholane triterpenoids reverse P-glycoprotein (ABCB1)-mediated multidrug resistance in cancer cellsIoana Abraham, Sandeep Jain, Chung-Pu Wu, et al.
Frontiers in Oncology|June 2, 2020
M3814, a DNA-PK Inhibitor, Modulates ABCG2-Mediated Multidrug Resistance in Lung Cancer CellsZhuo-Xun Wu, Zheng Peng, Yuqi Yang, et al.
Pageof 64

Showing results (501-510 of 633) with videos related to

Sort By:
Pageof 64
Cancer Letters|October 31, 2024
Mobocertinib antagonizes multidrug resistance in ABCB1- and ABCG2-overexpressing cancer cells: In vitro and in vivo studiesXing-Duo Dong, Meng Zhang, Qiu-Xu Teng, et al.
Frontiers in Oncology|July 1, 2022
ERH Interacts With EIF2α and Regulates the EIF2α/ATF4/CHOP Pathway in Bladder Cancer CellsKun Pang, Yang Dong, Lin Hao, et al.
Frontiers in Oncology|November 9, 2020
Sapitinib Reverses Anticancer Drug Resistance in Colon Cancer Cells Overexpressing the ABCB1 TransporterHai-Ling Gao, Pranav Gupta, Qingbin Cui, et al.
Frontiers in Cell and Developmental Biology|January 11, 2021
Establishment and Characterization of a Topotecan Resistant Non-small Cell Lung Cancer NCI-H460/TPT10 Cell LineZi-Ning Lei, Qiu-Xu Teng, Wei Zhang, et al.
Molecular Cancer|September 4, 2020
Characterization of a novel HDAC/RXR/HtrA1 signaling axis as a novel target to overcome cisplatin resistance in human non-small cell lung cancerWenjing Wang, Mengyue Zhao, Lijuan Cui, et al.
Molecular Pharmacology|April 9, 2005
Analysis of the in vivo functions of Mrp3Martin G Belinsky, Paul A Dawson, Irina Shchaveleva, et al.
Cancers|September 28, 2021
VKNG-1 Antagonizes ABCG2-Mediated Multidrug Resistance via p-AKT and Bcl-2 Pathway in Colon Cancer: In Vitro and In Vivo StudySilpa Narayanan, Ying-Fang Fan, Nehaben A Gujarati, et al.
ACS Nano|January 24, 2024
Bioactive Ceria Nanoenzymes Target Mitochondria in Reperfusion Injury to Treat Ischemic StrokeJun Liao, Yi Li, Li Fan, et al.
Biochemical Pharmacology|August 11, 2010
Marine sponge-derived sipholane triterpenoids reverse P-glycoprotein (ABCB1)-mediated multidrug resistance in cancer cellsIoana Abraham, Sandeep Jain, Chung-Pu Wu, et al.
Frontiers in Oncology|June 2, 2020
M3814, a DNA-PK Inhibitor, Modulates ABCG2-Mediated Multidrug Resistance in Lung Cancer CellsZhuo-Xun Wu, Zheng Peng, Yuqi Yang, et al.
Pageof 64